CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to develop efficient methods for producing pure single enantiomers of biologically active substances, which are essential for various industries. By combining synthesis techniques with advanced separation methods, the project seeks to streamline production processes.
Several industries have an increasing interest in improving their access to pure single enantiomers of biologically active substances.
The latter often form the basis for valued added products relevant for, among others, the pharmaceutical, cosmetic, and food industries.
Up to now there exist two generally rivalling concepts for producing pure enantiomers.
One approach is based on developing and applying enantioselective synthesis techniques, which often consist of a large number of reaction ste…
MAX-PLANCK-GESELLSCHAFT ZUR FORDERUNG DER WISSENSCHAFTEN EV
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Germany, LEVERKUSEN
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Sweden, Sodertaelje
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Germany, MAGDEBURG
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
Italy, Milano
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
